Congressional Subcommittee Hears Testimony on FDA LDT Rule

DURING A MARCH 21 HEARING CONVENED by the U.S. House Energy and Commerce Subcommittee on Health, key members of Congress came under fire from representatives of clinical laboratory groups over the Food and Drug Administration’s (FDA’s) proposed rule to regulate laboratory developed tests (LDTs). The participants also disagreed over whether the Verifying Accurate, Leading-edge IVCT …

Congressional Subcommittee Hears Testimony on FDA LDT Rule Read More »

To access this post, you must purchase The Dark Report.

Congressional Subcommittee Hears Testimony on FDA LDT Rule

Lab industry stakeholders warn members of Congress about the flaws in the FDA’s plan to regulate LDTs

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month